The goal of this clinical trial is to compare two intraoperative kappa-angle compensation strategies during small incision lenticule extraction (SMILE) using the VisuMax 800 platform in patients with relatively large kappa-angle offsets. Angle kappa represents the difference between the visual axis and the pupil center. In patients with a large offset, pupil-centered treatment may lead to decentration of the optical zone, which can induce higher-order aberrations and affect postoperative visual quality. The VisuMax 800 system allows intraoperative adjustment of the treatment center based on the measured offset, making different compensation strategies possible. The main questions this study aims to answer are: Does low kappa-angle compensation (50%) result in lower postoperative higher-order aberrations than high compensation (100%)? Does the compensation strategy influence visual acuity, refractive outcomes, contrast sensitivity, and subjective visual quality after SMILE? Are the measurements obtained from different diagnostic devices consistent when evaluating kappa-related parameters? Researchers will compare SMILE with low compensation to SMILE with high compensation to determine which strategy provides better optical quality and visual performance. Participants will: Undergo SMILE surgery using either low or high kappa-angle compensation Complete scheduled postoperative examinations at 1 month, 3 months, and 6 months Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and patient-reported visual outcomes Be monitored for safety outcomes and adverse events during follow-up
Angle kappa refers to the offset between the visual axis and the pupil center and is an important factor influencing the centration of the treatment zone during corneal refractive surgery. In patients with relatively large offsets, pupil-centered treatment may lead to decentered lenticule extraction, which can induce higher-order aberrations, especially coma, and may reduce postoperative visual quality. Small incision lenticule extraction (SMILE) is a widely used corneal refractive procedure with good safety and predictability. The new-generation VisuMax 800 femtosecond laser system incorporates machine vision-assisted alignment, allowing the surgeon to adjust the treatment center according to the measured displacement between the corneal vertex and the pupil center. This enables intraoperative compensation based on the kappa-angle offset. Previous studies in excimer laser surgery have evaluated different proportions of kappa-angle compensation, but prospective randomized studies in SMILE are limited, particularly in patients with relatively large offsets. In addition, the optimal amount of compensation during SMILE has not been clearly determined. This study is a single-center, randomized, parallel-group clinical trial designed to compare two predefined compensation strategies during SMILE using the VisuMax 800 platform. Patients aged 18-40 years with stable myopia or myopic astigmatism and a kappa-related displacement of at least 0.20 mm will be enrolled and randomly assigned to one of two groups. Participants in the low-compensation group will undergo SMILE with the treatment center shifted by 50% of the measured offset coordinates, while participants in the high-compensation group will undergo SMILE with 100% compensation of the measured offset. All surgeries will be performed using the same surgical protocol, and postoperative management will be identical in both groups. Participants will undergo routine ophthalmic examinations before surgery and at scheduled follow-up visits after surgery. The primary evaluation will assess postoperative higher-order aberrations at 3 months. Secondary evaluations will include visual acuity, refractive outcomes, refractive stability, contrast sensitivity, patient-reported visual quality, optical zone centration, and safety outcomes. In addition, measurements obtained from different diagnostic devices will be compared to assess consistency. The results of this study will help determine the optimal intraoperative compensation strategy for SMILE in patients with large kappa-angle offsets and may contribute to improving postoperative visual quality and refractive accuracy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It remains, in essence, an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma together with a small incision, and then remove the lenticule through that incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the high-level compensation group, a high level of compensation for the kappa angle was applied during the preoperative parameter input.
SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It is essentially an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma and a small incision, and then remove the lenticule through the incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the low-level compensation group, a low level of kappa-angle compensation was applied during the preoperative parameter input.
Coma aberration
Coma aberration measured by wavefront aberrometry to evaluate the effect of intraoperative kappa-angle compensation on postoperative optical quality.
Time frame: 3 months after surgery
Higher-order aberrations
Total higher-order aberrations, spherical aberration, and trefoil aberration measured using wavefront aberrometry under standardized conditions to evaluate postoperative optical quality.
Time frame: 1 month, 3 months, and 6 months after surgery
Optical zone decentration
Decentration of the optical zone measured using corneal topography by determining the displacement between the optical zone center and the corneal vertex.
Time frame: 3 months after surgery
Visual Acuity
Binocular uncorrected distance visual acuity and corrected distance visual acuity measured using standardized visual acuity charts to evaluate visual performance and safety.
Time frame: 1 month, 3 months, and 6 months after surgery
Manifest refraction
Postoperative sphere, cylinder, and spherical equivalent measured by manifest refraction.
Time frame: 1 month, 3 months, and 6 months after surgery
Refractive accuracy
Proportion of eyes within predefined ranges of target refraction to evaluate refractive predictability.
Time frame: 1 month, 3 months, and 6 months after surgery
Refractive stability
Refractive stability will be assessed as the change in manifest spherical equivalent refraction between postoperative visits.
Time frame: 1 month to 6 months after surgery
Contrast sensitivity
Contrast sensitivity will be measured using a standardized contrast sensitivity testing system (CSV-1000, VectorVision, USA) at multiple spatial frequencies.
Time frame: 3 months after surgery
Quality of Vision (QoV) score
Visual symptoms will be assessed using the Quality of Vision (QoV) questionnaire, which evaluates the frequency, severity, and bothersome nature of visual disturbances. Scores are recorded on ordinal scales, with higher scores indicating worse visual quality.
Time frame: 3 months after surgery
Patient satisfaction score
Patient satisfaction will be assessed using a 5-point rating scale. Scores range from 1 to 5, with higher scores indicating greater satisfaction.
Time frame: 3 months after surgery
Adverse events
Incidence of intraoperative or postoperative complications, including loss of corrected distance visual acuity and other clinically significant events.
Time frame: Up to 6 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.